Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does CANDESARTAN Cause Maternal exposure timing unspecified? 28 Reports in FDA Database

Lower Your Cholesterol — The Natural Way

The Oxidized Cholesterol Strategy: a science-backed plan for heart health.

See the Strategy

According to the FDA Adverse Event Reporting System (FAERS), 28 reports of Maternal exposure timing unspecified have been filed in association with CANDESARTAN. This represents 0.3% of all adverse event reports for CANDESARTAN.

28
Reports of Maternal exposure timing unspecified with CANDESARTAN
0.3%
of all CANDESARTAN reports
28
Deaths
28
Hospitalizations

How Dangerous Is Maternal exposure timing unspecified From CANDESARTAN?

Of the 28 reports, 28 (100.0%) resulted in death, 28 (100.0%) required hospitalization, and 28 (100.0%) were considered life-threatening.

Is Maternal exposure timing unspecified Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for CANDESARTAN. However, 28 reports have been filed with the FAERS database.

What Other Side Effects Does CANDESARTAN Cause?

Off label use (1,911) Fatigue (1,468) Dyspnoea (1,456) Pain (1,455) Drug ineffective (1,428) Headache (1,371) Nausea (1,282) Dizziness (1,237) Vomiting (1,202) Diarrhoea (1,145)

What Other Drugs Cause Maternal exposure timing unspecified?

RITUXIMAB (402) METHOTREXATE (350) ADALIMUMAB (343) DICLOFENAC (331) TOCILIZUMAB (327) HYDROXYCHLOROQUINE (309) FOLIC ACID (304) INFLIXIMAB (303) LEFLUNOMIDE (302) SECUKINUMAB (301)

Which CANDESARTAN Alternatives Have Lower Maternal exposure timing unspecified Risk?

CANDESARTAN vs CANDESARTAN CILEXETIL CANDESARTAN vs CANDESARTAN CILEXETIL\HYDROCHLOROTHIAZIDE CANDESARTAN vs CANGRELOR CANDESARTAN vs CANIS LUPUS FAMILIARIS SKIN CANDESARTAN vs CANNABIDIOL

Related Pages

CANDESARTAN Full Profile All Maternal exposure timing unspecified Reports All Drugs Causing Maternal exposure timing unspecified CANDESARTAN Demographics